OVERIVIEW: The Ambrose Monell Foundation does not maintain a specific disease grantmaking program. However, it funds a wide range of projects related to disease research and treatment.
IP TAKE: This is an accessible funder that offers medium-sized grants; however, grantseekers should expect competition from established organizations in healthcare.
PROFILE: The Ambrose Monell Foundation was established in the mid-1950s in honor of Maude Monell Vetlesen first husband Ambrose, who died at the age of 48 “after a long illness.” The foundation prefers a broad approach to its grantmaking and does not name specific areas of funding interest. However, tax filings demonstrate that this funder supports a wide range of projects associated with disease research and treatment.
Ambrose Monell typically awards larger hospitals and research institutions. Past grantees include Massachusetts General Hospital for its cancer diagnosis and treatment programs, as well as the Memorial Sloan-Kettering Cancer Center. Grant amounts generally range from about $25,000 to $250,000; however, Ambrose sometimes awards grants in the $300,000 to $500,000 range. Additionally, its grants support both general operating purposes and specific programs.
Though the foundation appears to prioritize cancer work, Ambrose Monell also supports the diagnosis, research, and treatment of other diseases and conditions, such as Alzheimer’s, blindness, and multiple sclerosis. To learn more about the kinds of organizations receiving Monell support, download its current grants list.
The foundation accepts unsolicited letters of inquiry, which must be submitted electronically. Ambrose Monell does not review hard copy applications.
- Ambrose K. Monell, President and Director
- Maurizio Morello, Executive Vice President